Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a two-phase study that compares performance growth pre-implant with current hearing aid (HA) technology versus post-implant with a cochlear implant (CI) in children with either asymmetric hearing loss (AHL) or single-sided deafness (SSD). Post-implant performance with a CI alone is expected to outperform pre-implant performance with a HA. The study also evaluates the effectiveness of bimodal hearing defined as a CI in the poor ear and a HA in the better ear for AHL or a CI in the poor ear and normal hearing in the better ear for SSD compared to pre-implant performance. The study examines factors contributing to CI outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Maximum Age: 14
Healthy Volunteers: t
View:

• At least 4 ys of age and up to 14 yrs, 11 mos of age and able to complete all investigational procedures.

• Parents and child fluent in English. Parents desire bilateral hearing for their child, are willing to comply with study requirements, including the pre-implant HA phase, and are able to provide informed consent.

• Poor ear (AHL/SSD): PTA at .5, 1, 2 kHz \> 70 dB HL; Aided CNC word recognition score at 60 dB SPL \< 40%; SPHL duration ≥ 6 mos and ≤ 10 yrs at time of CI surgery; If \> 5 yrs of age, evidence of non-congenital SPHL onset (e.g., passed newborn hearing screening); If ≤ 5 yrs of age, no restrictions on SPHL onset.

• Better ear

• AHL: PTA at .5, 1, 2, 4 kHz \> 25 and ≤ 60 dB HL; Aided CNC word score at 60 dB SPL ≥ 55%; Currently using a HA; Stable hearing for the past 6-mo period. Stable is defined as thresholds that have not declined by more than 20 dB at three or more octave-interval audiometric frequencies.

• SSD: PTA at .5, 1, 2, 4 kHz ≤ 25 dB HL; CNC word score at 60 dB SPL ≥ 70%; Stable hearing for the past 6-mo period.

• Both ears of NH participants: PTA at .5, 1, 2, 4 kHz ≤ 25 dB HL.

• To continue with cochlear implantation and into the CI phase of the study: Indication, via imaging, of a normal cochlear nerve and of cochlear anatomy in the ear to be implanted that allows full insertion of the electrode array. Imaging modality is at the discretion of the surgeon. In addition, better ear hearing must be stable throughout the HA phase.

Locations
United States
California
Keck School of Medicine of the University of Southern California
RECRUITING
Los Angeles
Minnesota
Fairview Health Services
RECRUITING
Minneapolis
Missouri
Washington University School of Medicine/St Louis Children's Hospital
RECRUITING
St Louis
Oklahoma
Hearts for Hearing
RECRUITING
Oklahoma City
Pennsylvania
Children's Hospital of Philadelphia - Buerger Center
RECRUITING
Philadelphia
Contact Information
Primary
Noel Dwyer, AuD
NDwyer@wustl.edu
314-362-7245
Backup
Laura Holden, AuD
laurakholden@wustl.edu
314-362-7245
Time Frame
Start Date: 2021-09-20
Estimated Completion Date: 2026-08
Participants
Target number of participants: 80
Treatments
Experimental: AHL/SSD
Children with asymmetric hearing loss or single-sided deafness
Authors
Kristin Gravel
Related Therapeutic Areas
Sponsors
Leads: Washington University School of Medicine
Collaborators: University of Southern California, Hearts for Hearing, Children's Hospital of Philadelphia, St. Louis Children's Hospital, University of Minnesota

This content was sourced from clinicaltrials.gov